The Role of Physiotherapy in the New Treatment Landscape for Haemophilia

Publication date

2021-06-26

Authors

Lobet, Sébastien
Timmer, Merel
Königs, Christoph
Stephensen, David
McLaughlin, Paul
Duport, Gaetan
Hermans, Cédric
Mancuso, Maria Elisa

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

The physiotherapist plays an essential role for people with haemophilia, an inherited bleeding disease responsible for musculoskeletal complications. Yet, with the advent of new and advanced therapies, the medical landscape is changing, and physiotherapy must adapt alongside. This paper considers whether there will still be a need for physiotherapy in the era of advanced therapies, and discusses ways in which services should evolve to complement emerging treatment paradigms for haemostasis in people with haemophilia. Ultimately, physiotherapy will remain an important element of care, even for people with little joint damage and low risks in the era of the new mild phenotype. However, competencies will need to evolve, and physiotherapists in both primary care and specialist treatment centres should work with haematology colleagues to develop more sensitive tools for detecting early joint changes. Physiotherapists will also play a crucial role in counselling and physically coaching, monitoring the musculoskeletal status of people with haemophilia who have transitioned to new treatments.

Keywords

EHL concentrates, Emicizumab, Gene therapy, Haemophilia, Physiotherapy, Trough levels, General Medicine, Review, Journal Article

Citation

Lobet, S, Timmer, M, Königs, C, Stephensen, D, McLaughlin, P, Duport, G, Hermans, C & Mancuso, M E 2021, 'The Role of Physiotherapy in the New Treatment Landscape for Haemophilia', Journal of Clinical medicine, vol. 10, no. 13, 2822, pp. 1-11. https://doi.org/10.3390/jcm10132822